首页> 外文期刊>Clinical nuclear medicine >Adrenal Metastasis of a Poorly Differentiated Adenocarcinoma Mimicking a Pheochromocytoma on F-18-FDOPA PET/CT
【24h】

Adrenal Metastasis of a Poorly Differentiated Adenocarcinoma Mimicking a Pheochromocytoma on F-18-FDOPA PET/CT

机译:F-18-FDOPA PET / CT上模仿嗜铬细胞瘤的分化差的腺癌的肾上腺转移

获取原文
获取原文并翻译 | 示例
           

摘要

We report the surprising intense uptake of F-18-FDOPA in a right adrenal metastasis of a poorly differentiated metastatic adenocarcinoma of unknown primary mimicking a pheochromocytoma in a hemodialyzed patient with the typical Menard's triad and increased serum catecholamines. Our observation emphasizes that F-18-FDOPA is not a specific radiotracer for pheochromocytoma and paraganglioma investigation, although it is currently and successfully used in this clinical setting. Moreover, we underline that kidney failure may be responsible for abnormally high serum catecholamines values even in subjects without pheochromocytoma, leading to erroneous diagnostic conclusions particularly in patients with adrenal masses.
机译:我们报道F-18-FDOPA在未知原发性低分化转移性腺癌的右肾上腺转移中令人惊讶地大量摄取,该转移性腺癌与典型的Menard's三联征和血中儿茶酚胺增加的血液透析患者相似,嗜铬细胞瘤。我们的观察结果强调,F-18-FDOPA并不是嗜铬细胞瘤和副神经节瘤研究的特定放射性示踪剂,尽管目前已成功地在该临床环境中使用。此外,我们强调指出,即使在没有嗜铬细胞瘤的受试者中,肾功能衰竭也可能导致异常高的血清儿茶酚胺值,从而导致错误的诊断结论,尤其是在肾上腺肿块患者中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号